Real-time imaging shows that bacterial resilience to antibiotics is not caused by a few ‘persisters’, but is a ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

AbbVie (NYSE:ABBV) said it has received FDA approval for its intravenous antibiotic treatment Emblaveo. The FDA approved Emblaveo, a combination of aztreonam and avibactam, for use in combination with ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

A new report has been released looking at the infection rate of Group A streptococcal, otherwise known as scarlet fever, this ...

Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the ...

In 2017, a tragic incident unfolded in a Nevada hospital. A woman, admitted for pneumonia, tragically succumbed to multiple ...

A report has issued advice to doctors to tell them to use antibiotics early when people get an infection because the results ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

First-line antibiotics for uncomplicated UTI remain more effective than fluoroquinolones and beta-lactams in a retrospective ...

AstraDx will receive $3 million to develop a test that detects and identifies pathogens and analyzes antimicrobial susceptibility in whole blood drawn from newborns.

UCSF model shortens tuberculosis treatment by over three months through optimal combinations UCSF creates a groundbreaking approach to tuberculosis management by optimizing antibiotic therapies.